BCHE and Atrophy: We demonstrated that the serological markers, cholinesterase and cholesterol, increased after H. pylori eradication therapy in H. pylori-positive hemodialysis patients, especially in those with gastric mild–moderate atrophy who has ability for recovery of gastric mucosal atrophy after eradication therapy.(28) Therefore, eradication therapy might improve nutritional status in H. pylori-postive hemodialysis patients.